Procter & Gamble Health Ltd.
Industry Group: Pharmaceuticals
Country/Region: India
Identifier: BOM:500126
Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Pharmaceuticals 530 out of 847
Universe
Global Universe 11569 out of 14947
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the non-India based rated subjects, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
Procter & Gamble Health Ltd. |
32.8
High
|
530 out of 847 |
Zhejiang Ausun Pharmaceutical Co., Ltd. |
32.9
High
|
537 out of 847 |
Changzhou Qianhong Biopharma Co., Ltd. |
36.8
High
|
719 out of 847 |
Evolus, Inc. |
39.1
High
|
791 out of 847 |
Saudi Pharmaceutical Industries & Medical Appliances Corp. |
44.3
Severe
|
843 out of 847 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Procter & Gamble Health Ltd.'s Exposure is Medium
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
Procter & Gamble Health Ltd.'s Management of ESG Material Risk is Average